Back to Semaglutide research
semaglutide glp 1 agonist rct 2022-08-31 ClinicalTrials

Oral Semaglutide's Potential to Halt Heart Disease Progression After Acute Coronary Syndrome

The POST-ACS Study

Abstract

Potential Impact of Oral Semaglutide on Coronary Artery Disease Progression Following Acute Coronary Syndrome: The POST-ACS Study NCT ID: NCT05322200 Status: UNKNOWN Sponsor: Swansea Bay University Health Board Start: 2022-08-31 | Completi…

semaglutide glp 1 agonist oxidative-stress
Source: clinicaltrials:NCT05322200 · Ingested 2026-04-07 · Digest: gemini-2.5-flash